[HTML][HTML] Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek, Ö Met… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
[HTML][HTML] Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek, Ö Met… - … for ImmunoTherapy of …, 2020 - jitc.bmj.com
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma.
TH Borch, R Andersen, E Ellebaek, Ö Met… - … for Immunotherapy of …, 2020 - europepmc.org
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek… - Journal for …, 2020 - pubmed.ncbi.nlm.nih.gov
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
[PDF][PDF] Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek, Ö Met… - Age (median … - scholar.archive.org
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek… - Journal for …, 2020 - research.regionh.dk
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek… - Journal for …, 2020 - search.proquest.com
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
[HTML][HTML] Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
TH Borch, R Andersen, E Ellebaek, Ö Met… - … for ImmunoTherapy of …, 2020 - jitc.bmj.com
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma.
TH Borch, R Andersen, E Ellebaek, Ö Met… - … for Immunotherapy of …, 2020 - europepmc.org
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …
lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s …